NHC
National HealthCare Corporation
227.70$
+1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.3% | -1.2% | -2.0% | +16.8% | +8.6% | +1.2% | +0.3% | +2.1% | +1.0% | -1.2% | +6.9% | – | |
| – | +2.1% | -1.8% | -1.7% | +18.5% | +9.8% | -2.6% | -0.7% | +2.9% | +0.0% | +0.8% | +2.9% | – | |
| – | +8.1% | -0.3% | -2.5% | +14.1% | +6.5% | +7.8% | +1.9% | +0.7% | +2.5% | -4.3% | +13.2% | – | |
| – | +13.3% | -9.5% | +2.1% | +3.0% | +192.2% | -64.3% | -0.3% | +0.2% | +7.4% | -4.5% | -0.9% | – | |
| – | +1.5% | +4.4% | -10.0% | +19.3% | +2.6% | +5.8% | -0.4% | +4.2% | +0.9% | -4.7% | +2.4% | – | |
| – | +54.5% | -22.3% | +44.1% | -6.5% | +26.2% | +15.8% | +10.8% | -10.9% | +9.0% | -2.6% | +51.7% | – | |
| – | -27.3% | -17.9% | -100.0% | – | +34.7% | -10.3% | -5.4% | -26.9% | -44.0% | -67.0% | -95.2% | – | |
| – | +161.4% | -2.6% | +2.5% | +58.6% | -89.6% | +621.8% | -26.4% | +69.1% | -40.9% | +39.5% | +20.5% | – | |
| – | +122.6% | +8.8% | +0.3% | +61.6% | -99.8% | +40,728.6% | -29.5% | +66.4% | -48.2% | +25.6% | +54.6% | – | |
| – | +173.5% | -7.7% | +2.4% | +59.4% | -85.8% | +429.6% | -26.3% | +65.4% | -36.7% | +44.3% | +12.4% | – | |
| – | +100.0% | -4.4% | -0.9% | +53.2% | -71.8% | +186.2% | -20.5% | +48.4% | -33.3% | +26.8% | +15.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.